Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Trials|September 6, 2018
Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trialYushu Zhou, Baiming Zhao, Wanyin Wu, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 16, 2023
Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathwayQing Tang, Xi Wang, Qichun Zhou, et al.Small Science|July 14, 2025
Targeting Frequent Efferocytosis in Tumor Microenvironment is a New Direction for Cancer TreatmentGangxing Zhu, Xinliang Wan, Wanyin Wu, et al.Carcinogenesis|May 5, 2023
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancerQing Tang, Qichun Zhou, Jing Li, et al.Genes & Diseases|March 3, 2025
Treating human cancer by targeting EZH2Mengfei Xu, Chunyan Xu, Rui Wang, et al.Frontiers in Medicine|March 13, 2026
In-hospital survival characteristics and predictive model for patients with malignant tumors and sepsisZiyan Gan, Jiahao Zhang, Jinpeng Huang, et al.Journal of Experimental & Clinical Cancer Research : CR|September 13, 2015
Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cellsJingjing Wu, Shunyu Zhao, Qing Tang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2024
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatmentsQing Tang, Siqi Wu, Baiming Zhao, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 22, 2023
Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathwayRui Wang, Zhiyin Deng, Zhiming Zhu, et al.Cancer Letters|September 2, 2019
MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancerSumei Wang, Do-Youn Oh, Vasiliki Leventaki, et al.Pageof 6